Melatonin as a potential modulator of Nrf2

被引:106
|
作者
Ahmadi, Zahra [1 ]
Ashrafizadeh, Milad [2 ]
机构
[1] Islamic Azad Univ, Shoushtar Branch, Dept Basic Sci, Shoushtar 5563584, Iran
[2] Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz 1455742, Iran
关键词
Antioxidant response element; Cancer therapy; Melatonin; Nrf2 signaling pathway; Oxidative stress; NF-KAPPA-B; EARLY BRAIN-INJURY; OXIDATIVE STRESS; SIGNALING PATHWAY; ACTIVATION; PROTECTS; EXPRESSION; NEUROINFLAMMATION; APOPTOSIS; DRUGS;
D O I
10.1111/fcp.12498
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nuclear factor erythroid 2-related factor 2 (Nrf2) is considered as the sensor of oxidative stress, and the main aim of this signaling pathway is to maintain physiological condition by induction of redox balance. Also, this pathway exerts anti-inflammatory effects via antioxidant response element. Oxidative stress is a key factor in a variety of pathological conditions and high level of oxidative stress is associated with damages in lipids, proteins, genetic material, and cell membrane. Multiple drugs have been developed in order to diminish oxidative stress. However, synthetic drugs suffer from various drawbacks such as high cost and side effects. On the other hand, naturally occurring compounds are of interest due to their minimal side effects and valuable biological activities. Melatonin is a hormone of pineal gland which is found in different plants. This compound has a variety of favorable biological and therapeutic activities such as antioxidant, anti-inflammatory, anti-tumor, anti-diabetic, and cardioprotection. At the present review, we demonstrate that Nrf2 signaling pathway explains some of the therapeutic and biological effects of melatonin.
引用
收藏
页码:11 / 19
页数:9
相关论文
共 50 条
  • [21] Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
    Tascioglu Aliyev, Alev
    Panieri, Emiliano
    Stepanic, Visnja
    Gurer-Orhan, Hande
    Saso, Luciano
    MOLECULES, 2021, 26 (07):
  • [22] Melatonin enhances porcine embryo development via the Nrf2/ARE signaling pathway
    Kim, Eui Hyun
    Kim, Geon A.
    Taweechaipaisankul, Anukul
    Lee, Seok Hee
    Qasim, Muhammad
    Ahn, Curie
    Lee, Byeong Chun
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2019, 63 (03) : 175 - 185
  • [23] Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway
    Tao, Yangyang
    Zhao, Qinglong
    Lu, Chengbo
    Yong, Weilin
    Xu, Mingyuan
    Wang, Zhuo
    Leng, Xiaoping
    FASEB JOURNAL, 2024, 38 (10):
  • [24] Modulation of Nrf2 and NF-κB Counteracts Multiple Manifestations of Experimental Diabetic Neuropathy: Potential of Sulforaphane and Melatonin
    Negi, Geeta
    Sharma, Shyam S.
    FASEB JOURNAL, 2012, 26
  • [25] Nrf2 Positively Regulates FGF21 in Diabetic Mice: A Potential Efficacy Biomarker of Nrf2 Induction
    Furusawa, Yuki
    Uruno, Akira
    Yagishita, Yoko
    Yamamoto, Masayuki
    DIABETES, 2014, 63 : A485 - A485
  • [26] Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
    Russo, Maria
    Spagnuolo, Carmela
    Russo, Gian Luigi
    Skalicka-Wozniak, Krystyna
    Daglia, Maria
    Sobarzo-Sanchez, Eduardo
    Nabavi, Seyed Fazel
    Nabavi, Seyed Mohammad
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2018, 58 (08) : 1391 - 1405
  • [27] Nrf2 in human cancers: biological significance and therapeutic potential
    Tian, Yu
    Tang, Lixin
    Wang, Xin
    Ji, Yanqin
    Tu, Yanyang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (08): : 3935 - 3961
  • [28] The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes
    Vivarini, Aislan de Carvalho
    Lopes, Ulisses Gazos
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 9
  • [29] Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
    Zhang, Juan
    Xu, Hong-Xi
    Zhu, Jia-Qian
    Dou, Yao-Xing
    Xian, Yan-Fang
    Lin, Zhi-Xiu
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (10): : 3029 - 3041
  • [30] Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
    da Costa, Rafael M.
    Rodrigues, Daniel
    Pereira, Camila A.
    Silva, Josiane F.
    Alves, Juliano V.
    Lobato, Nubia S.
    Tostes, Rita C.
    FRONTIERS IN PHARMACOLOGY, 2019, 10